Serial Magnetic Resonance Imaging of Cerebral Atrophy in Preclinical Alzheimer's Disease
Lancet 353:2125, Fox,N.C.,et al, 1999
Variability in Annual Mini-Mental State Examination Score in Patients with Probable Alzheimer Disease
Arch Neurol 56:857-862, Clark,C.M.,et al, 1999
Atypical Form of Amyotrophic Lateral Sclerosis
JNNP 66:581-585, Sasaki,S.&Iwata,M., 1999
Practice Parameter:The Care of the Patient with Amyotrophic Lateral Sclerosis (An Evidence-Based Review), Report of the Quality Standards Subcommittee of the AAN
Neurol 52:1311-1323, Miller,R.G.,et al, 1999
Paraneoplastic Syndromes
Arch Neurol 56:405-408, Dalmau,J.O.&Posner,J.B., 1999
Medial Temporal Lobe Atrophy on MRI in Dementia with Lewy Bodies
Neurol 52:1153-1158, Barber,R.,et al, 1999
Clinicopath Conf:Multisystem Neurodegenerative Disease with Dementia Pugilistica
NEJM 340:1269-1277, Case 12-1999, 1999
Neurology and the Skin
JNNP 66:417-430, Hurko,O.&Provost,T.T., 1999
Proton Magnetic Resonance Spectroscopy Pattern of Progressive Multifocal Leukoencephalopathy in AIDS
JNNP 66:520-523, Iranzo,A.,et al, 1999
Magnetic Resonance Imaging-Based Volumetry Differentiates Idiopathic Parkinson's Syndrome from Multiple System Atrophy and Progressive Supranuclear Palsy
Ann Neurol 45:65-74, Schulz,J.B.,et al, 1999
Spastic Paraparesis after Anaesthesia
Lancet 353:554, Lee,P.,et al, 1999
Primary and Transitional Progressive MS,A Clinical and MRI Cross-Sectional Study
Neurol 52:839-845, Stevenson,V.L.,et al, 1999
Efficacy and Safety of Rivastigmine in Patients with Alzheimer's Disease:International Randomised Controlled
BMJ 318:633-640, 615, Rosler,M.,et al, 1999
Mild Cognitive Impairment, Clinical Characterization and Outcome
Arch Neurol 56:303-308, Petersen,R.C.,et al, 1999
Diagnosis, Management, and Treatment of Alzheimer Disease, A Guide for the Internist
Arch Int Med 159:789-798, Richards,S.S.&Hendrie,H.C., 1999
Cost-Effectiveness of Donepezil in the Treatment of Mild or Moderate Alzheimer's Disease
Neurol 52:1138-1145,1115, Neumann,P,J.,et al, 1999
Hypoxic/Ischaemic Brain Damages, Especially Pallidal Lesions, in Heroin Addicts
Forensic Sci Int 102:51-59, Andersen,S.N. &Skullerud,K., 1999
Alzheimers Disease with Asymmetric Parietal Lobe Atrophy: A Case Report
J Neurol Sci 160:96-99, Kaida,K.-I.,et al, 1998
The Muscular Dystrophies
BMJ 317:991-995, Emery,A.E.H., 1998
Cardiac Involvement in Genetically Confirmed Facioscapulohumeral Muscular Dystrophy
Neurol 51:1454-1456, Laforet,P.,et al, 1998
Clinicopath Conf
Sarcoidosis, Involving the Spinal Cord & Mediastinal Lymph Nodes, Case 8-1998, NEJM 338:747-754., , 1998
Attitudes of Patients with Amyotrophic Lateral Sclerosis and Their Care Givers Toward Assisted Suicide
NEJM 339:967-973,987, Ganzini,L.,et al, 1998
Olfactory Dysfunction in Guamanian ALS,Parkinsonism,and Dementia
Neurol 51:1672-1677, Ahlskog,J.E.,et al, 1998
Radiation-Associated Cerebral Blindness
Am J Ophthalmol 126:609-611, Pomeranz,H.D.,et al,, 1998
Granulomatous Compressive Thoracic Myelopathy as the Initial Manifestation of Wegener's Granulomatosis
Neurol 51:1769-1770, Kelly,P.J.,et al, 1998
Review of 23 Patients Affected by the Stiff Man Syndrome:Clinical Subdivision into Stiff Trunk (man) Syndrome,Stiff Limb Syndrome,and Progressive Encephalopmyelitis with Rigidity
JNNP 65:633-640, Barker,R.A.et al, 1998
MR Appearance of an Intracranial Dural Arteriovenous Fistula Leading to Cervical Myelopathy
Neurol 51:1131-1135, Hahnel,S.,et al, 1998
Placebo-Controlled Multicentre Randomised Trial of Interferon B-1b in Treatment of Secondary Progressive Multiple Sclerosis
Lancet 352:1491-1497,1486, European Study Group on Interferon B-1b in Seconda, 1998
The Efficacy of Ginkgo Biloba on Cognitive Function in Alzheimer Disease
Arch Neurol 55:1409-1415, Oken,B.S.,et al,, 1998
New Neuropathological Criteria for Alzheimer Disease
Arch Neurol 55:1174-1176, Hyman,B.T., 1998
Progressive Multifocal Leukoencephalopathy, HIV, and Highly Active Antiretroviral Therapy
NEJM 339:848-849, Cinque,P.,et al, 1998
Predictive Factors for Prolonged Survival in AIDS-Associated PML
Ann Neurol 44:341-349, Berger,J.R.,et al, 1998
Early Dopaminergic Drug-Induced Hallucinations in Parkinsonian Patients
Neurol 51:811-814, Goetz,C.G.,et al, 1998
Serum S-100 and Neuron-Specific Enolase for Prediction of Regaining Consciousness After Global Cerebral Ischemia
Stroke 29:2363-2366, Martens,P.,et al, 1998
Inherited Prothrombotic States and Ischaemic Stroke in Childhood
JNNP 65:508-511, Ganesan,V.,et al, 1998
Clinicopath Conf
Chronic Inflammatory Demyelinating Polyneuropathy, Case 13-1998, NEJM 338:1212-1219998., , 1998
MR Differential Diagnosis of Normal-Pressure Hydrocephalus and Alzheimer Disease:Significance of Perihippocampal Fissures
AJNR 19:813-819, Holodny,A.I.,et al, 1998
Spontaneous Thoracic Spinal Cord Herniation Through an Anterior Dural Defect
AJNR 19:1345-1348, 11851998., Dix,J.E.,et al, 1998
Transdural Spinal Cord Herniation:Imaging and Clinical Spectra
AJNR 19:1337-1344, 11851998., Watters,M.R.,et al, 1998
An Analysis of Extended Survival in Patients with Amyotrophic Lateral Sclerosis Treated with Riluzole
Arch Neurol 55:526-528, Riviere,M.,et al, 1998
Magnetic Resonance Imaging of Muscle in Amyotrophic Lateral Sclerosis
Neurol 51:110-113, Bryan,W.W.,et al, 1998
Congenital Muscular Dystrophy:Use of Brain MR Imaging to Predict Merosin Deficiency
Radiology 206:811-816, Lamer,S.,et al, 1998
MR Findings of Werdnig-Hoffmann Disease in Two Infants
AJNR 19:550-552, Hsu,C.,et al, 1998
Distal Hereditary Upper Limb Muscular Atrophy
JNNP 64:217-220, Gross,D.W.,et al, 1998
Estimation of Brainstem Neuronal Loss in ALS with in Vivo Proton Magnetic Resonance Spectroscopy
Neurol 50:72-77, Cwik,V.A.,et al, 1998
Risk of Amyotrophic Lateral Sclerosis & History of Physical Activity, A Population Study
Arch Neurol 55:201-206, Longstreth,W.T.,et al, 1998
Toward Earlier Diagnosis of Amyotrophic Lateral Sclerosis, Revised Criteria
Neurol 50:768-772, Ross,M.A.,et al, 1998
The Genetics of Alzheimer Disease, Current Status and Future Prospects
Arch Neurol 55:294-296, Blacker,D.&Tanzi,R.E., 1998
Drop the Alzheimer's Drop Test
Neurol 50:588-591, Kardon,R.H., 1998
A 24-Week, Double-Blind, Placebo-Controlled Trial of Donepezil in Pts with Alzheimer's Disease
Neurol 50:136-145, Rogers,S.,et al, 1998